Please assess the completion status of the following clinical trial:

Trial Title: A Randomized Clinical Trial on Hemoglobin Dose and Patient Matching

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients receiving red cell transfusions or expected to receive one or more red cell transfusions~* Patients over 16 years of age~* Patients for whom height and weight information is available~* Patients who have consented to participate~Exclusion Criteria:~* Patients who are hemodynamically unstable (ongoing bleeding or hemolysis)~* Patients with a known hemolytic anemia (congenital or acquired)~* Patients with a positive Direct Antiglobulin Test (DAT)~* Patients for whom informed consent has not been obtained~* Patients where the hemoglobin concentration increment target is above 2g/dl.~* Patients with auto- or alloantibodies against RBCs.

- Gender: ALL
- Minimum Age: 16 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Hemoglobin dose (Type: EXPERIMENTAL): Intervention: Calculated red blood cell transfusion
- Standard treatment (Type: ACTIVE_COMPARATOR): Intervention: Standard red blood cell transfusion

Based on this trial design, predict the completion outcome and termination type (if applicable).